Literature DB >> 17030649

Natalizumab and immune cells.

Henry F McFarland, Steven Jacobson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030649     DOI: 10.1001/archneur.63.10.1366

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  3 in total

Review 1.  Review part 2: Human herpesvirus-6 in central nervous system diseases.

Authors:  Karen Yao; John R Crawford; Anthony L Komaroff; Dharam V Ablashi; Steven Jacobson
Journal:  J Med Virol       Date:  2010-10       Impact factor: 2.327

Review 2.  First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.

Authors:  Jacqueline Ann Nicholas; Michael Karl Racke; Jamie Imitola; Aaron Lee Boster
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

3.  Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients.

Authors:  Karen Yao; Susan Gagnon; Nahid Akhyani; Elizabeth Williams; Julie Fotheringham; Elliot Frohman; Olaf Stuve; Nancy Monson; Michael K Racke; Steven Jacobson
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.